Jorg Petersen

Summary

Publications

  1. doi request reprint Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study
    Jorg Petersen
    Liver Unit, Ifi Institute for Interdisciplinary Medicine, Asklepios Klinik St Georg Hamburg, Germany
    J Hepatol 56:520-6. 2012
  2. ncbi request reprint [Hepatitis B in clinical practice]
    Jorg Petersen
    Leberzentrum Hamburg, IFI Institut für Interdisziplinäre Medizin an der Asklepios Klinik St Georg, Hamburg
    Med Monatsschr Pharm 34:402-14; quiz 415-6. 2011
  3. doi request reprint Considerations for the long-term treatment of chronic hepatitis B with nucleos(t)ide analogs
    Jorg Petersen
    Ifi Institute for Interdisciplinary Medicine, Asklepios Klinik St Georg, Hamburg, Germany
    Expert Rev Gastroenterol Hepatol 6:683-93; quiz 694. 2012
  4. doi request reprint Experimental models and therapeutic approaches for HBV
    Maura Dandri
    Department of Internal Medicine, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Semin Immunopathol 35:7-21. 2013
  5. doi request reprint The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus
    Tassilo Volz
    Department of Internal Medicine, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    J Hepatol 58:861-7. 2013

Collaborators

Detail Information

Publications5

  1. doi request reprint Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study
    Jorg Petersen
    Liver Unit, Ifi Institute for Interdisciplinary Medicine, Asklepios Klinik St Georg Hamburg, Germany
    J Hepatol 56:520-6. 2012
    ..Aim of this study was to investigate the efficacy and safety of entecavir plus tenofovir combination in 57 CHB partial responders or multidrug resistant patients...
  2. ncbi request reprint [Hepatitis B in clinical practice]
    Jorg Petersen
    Leberzentrum Hamburg, IFI Institut für Interdisziplinäre Medizin an der Asklepios Klinik St Georg, Hamburg
    Med Monatsschr Pharm 34:402-14; quiz 415-6. 2011
    ..The recommendations of these guidelines are delineated. Most importantly the management of hepatitis B remains complicated and needs very experienced hepatologists...
  3. doi request reprint Considerations for the long-term treatment of chronic hepatitis B with nucleos(t)ide analogs
    Jorg Petersen
    Ifi Institute for Interdisciplinary Medicine, Asklepios Klinik St Georg, Hamburg, Germany
    Expert Rev Gastroenterol Hepatol 6:683-93; quiz 694. 2012
    ..Recent findings on whether and under what circumstances long-term therapy of CHB might be stopped are also discussed...
  4. doi request reprint Experimental models and therapeutic approaches for HBV
    Maura Dandri
    Department of Internal Medicine, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Semin Immunopathol 35:7-21. 2013
    ....
  5. doi request reprint The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus
    Tassilo Volz
    Department of Internal Medicine, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    J Hepatol 58:861-7. 2013
    ..We aimed at investigating the ability of the lipopeptide Myrcludex-B to block HBV spreading post-infection...